Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Humanized anti-CD70 binding agents and uses thereof

Humanized anti-CD70 binding agents and uses thereof

US Patent 8562987 · Granted Oct 22, 2013

Estimated economic value: $37,829,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic vaccine for hepatitis b virus (HBV) using the HBV core antigen2025
Synergistic effects between auristatin-based antibody drug conjugates and inhibi2025
Synergistic effects between auristatin-based antibody drug conjugates and inhibi2025
Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV PreS1 and/or PreS22025
Anti-CD45 antibodies and conjugates thereof2025
Anti-hypusine antibodies and uses thereof2024
Multispecific antigen-binding proteins2024
Humanized and affinity matured antibodies to FcRH5 and methods of use2024
Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV core antigen2024
Synergistic effects between auristatin-based antibody drug conjugates and inhibi2023
Synergistic effects between auristatin-based antibody drug conjugates and inhibi2023
Therapeutic vaccine for Hepatitis b virus (HBV) using the HBV PreS1 and/or PreS22022